Sandham, D. A., Barker, L., Brown, L., Brown, Z., Budd, D., Charlton, S. J., . . . Willis, J. (2017). Discovery of fevipiprant (NVP-QAW039), a potent and selective DP2 receptor antagonist for treatment of asthma. American Chemical Society.
Chicago Style (17th ed.) CitationSandham, David A., et al. Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP2 Receptor Antagonist for Treatment of Asthma. American Chemical Society, 2017.
MLA (9th ed.) CitationSandham, David A., et al. Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP2 Receptor Antagonist for Treatment of Asthma. American Chemical Society, 2017.
Warning: These citations may not always be 100% accurate.